1. From the Institute of Experimental Immunology, University of Zürich, CH-8091 Zürich, Switzerland; Novartis Pharma AG, S-386.110, CH-4002 Basel, Switzerland; and the Swiss Serum and Vaccine Institute, Department of Immunology, CH-3001 Bern, Switzerland